Zhang Shungji

Director of the VIP Area, Reproductive Center, CITIC Xiangya Reproductive and Genetic Specialty Hospital; Member of the Communist Party of China, Doctor, Associate Chief Physician; Youth Committee Member of the Reproductive Medicine Branch of the Chinese Medical Doctor Association; Youth Committee Member of the Reproductive Medicine Branch of Hunan Medical Association.
Graduated from the Clinical Medicine program of Xiangya Medical College, Central South University in 2004. Entered the Institute of Reproductive Medicine and Stem Cell Engineering, Central South University in 2004. Graduated in 2011 with a doctorate in reproductive medicine. Entered the Reproductive Center of CITIC Xiangya Reproductive and Genetic Specialty Hospital in 2011, managing 3000-4000 assisted reproductive patients annually. From 2012 to 2014, managed assisted reproduction for young standard patients, with a success rate consistently above 70%. At the end of 2015, began managing patients undergoing preimplantation genetic testing (PGT-A), with approximately 200-300 ovulation induction cycles per month and 50-100 frozen embryo transfer cycles after testing, achieving a transfer success rate of around 65%. At the end of 2019, began focusing on the management of patients with endometriosis and adenomyosis, and led a prospective cohort study on adenomyosis. From March 2022 to the present, I have been in the hospital's VIP center, comprehensively managing VIP assisted reproductive patients, including various types and categories of assisted reproductive patients. Over the past three years, the number of VIP patients has steadily increased, and the assisted reproduction success rate has remained above 70%.
Published 2 SCI articles and 3 domestic articles as the first author, and participated in the publication of 18 articles. Presided over 1 Changsha Municipal Natural Science Foundation project and 4 hospital clinical research projects. Participated in the completion of 2 national multicenter clinical research projects.
Participated in the development and revision of the clinical work operation instruction manual (SOP) for the hospital's reproductive center. Developed SOPs include: 《Short-acting long protocol SOP》, 《Frozen embryo PGT-A patient management SOP》, 《Growth hormone-assisted ovulation induction treatment SOP》, 《Adenomyosis patient management SOP》, 《Myoma patient assisted reproduction SOP》. Revised and updated SOPs include: 《PGT-A patient management SOP》, 《Endometriosis patient management SOP》, 《Short protocol SOP》.

Education Background:
2007/09-2011/07, Central South University, Institute of Reproductive Medicine and Stem Cell Engineering, Doctorate, Supervisor: Professor Lu Guangxiu
2004/09-2007/07, Central South University, Institute of Reproductive Medicine and Stem Cell Engineering, Master's Degree, Supervisor: Professor Lu Guangxiu
1999/09-2004/06, Xiangya Medical College, Central South University, Clinical Medicine, Bachelor's Degree

Work Experience:
1. 2019/12-Present, CITIC Xiangya Reproductive and Genetic Specialty Hospital, Associate Chief Physician
2. 2011/07-2019/11, CITIC Xiangya Reproductive and Genetic Specialty Hospital, Attending Physician
Research Projects (Topics) Led or Participated In:
1. CITIC Xiangya Reproductive and Genetic Specialty Hospital internal project, Clinical Research Project on Estrogen Pretreatment with Antagonist Protocol in Elderly Patients with Low Response, 2018/01-2021/08, presided over
2. CITIC Xiangya Reproductive and Genetic Specialty Hospital internal project, Establishing a model to predict the clinical outcome of adenomyosis patients using imaging indicators, 2021/07-2024/12, presided over
3. National multicenter clinical research project, Clinical research on whole embryo cryopreservation in patients with poor ovarian prognosis, 2021/10-2023/12, participated in
4. National multicenter clinical research project, Comparison of live birth rates between natural cycle endometrial preparation and hormone replacement therapy endometrial preparation in frozen embryo transfer cycles in normally ovulating populations: A randomized controlled clinical trial, 2021/10-2023/12, participated in
5. Changsha Municipal Natural Science Foundation research project, Prospective randomized controlled study of growth hormone-assisted ovulation induction to improve the euploidy of embryos in patients undergoing preimplantation genetic screening, 2022/1-2024/12, presided over
6. CITIC Xiangya Reproductive and Genetic Specialty Hospital internal project, A prospective randomized controlled study of HCG+GnRHa dual trigger and HCG trigger in antagonist protocols for patients with poor ovarian prognosis in Poseidon group 3 and 4, 2022/4-2024/12, presided over

Publications
1.Shun-Ji Zhang, Fei Gong, Ge Lin, Chang-Fu Lu, Hong-Mei Xiao, Guang-Xiu Lu. Influence of patient age and the number of good-quality-embryos transferred on multiple gestation in in vitro fertilization and embryo transfer Zhonghua Fu Chan Ke Za Zhi.2008 Aug;43(8):567-70.[Article in Chinese]
2. ShunJi Zhang, ChangFu Lu, Ge Lin, Fei Gong, GuangXiu Lu. The number of blastomeres in post-thawing embryos affects the rates of pregnancy and delivery in freeze-embryo-transfer cycles. J Assist Reprod Genet 2009;26(11-12):569-73.
3. Shunji Zhang, Yi Tang, Xiaojuan Wang, Yurong Zong, Xiaofeng Li, Sufen Cai, Hailan Ma, Hui Guo, Juan Song, Ge Lin, Guangxiu Lu 1 2, Fei Gong. Estrogen valerate pretreatment with the antagonist protocol does not increase oocyte retrieval in patients with low ovarian response: a randomized controlled trial. Hum Reprod 2022 Jun 30;37(7):1431-1439.
4. Gong F, Cai SF, Zhang SJ, Lu CF, Lin G, Lu GX*, A case report: successful pregnancy after controlled ovarian hyperstimulation by using short-acting gonadotropin releasing hormone agonist only, J Assist Reprod Genet, 2012,29(4):329-330.
5. Gong F, Li X, Zhang S, Ma H, Cai S, Li J, Lin GE, Lu G. A modified ultra-long pituitary downregulation protocol improved endometrial receptivity and clinical outcome for infertile patients with polycystic ovarian syndrome. Exp Ther Med.2015;10(5):1865-1870.
6. Zhang SP, Lu CF, Gong F, Xie PY, Hu L, Zhang SJ, Lu GX, Lin G. Polar body transfer restores the developmental potential of oocytes to blastocyst stage in a case of repeated embryo fragmentation. J Assist Reprod Genet. 2017;34(5):563-571.
7. Wei Zheng, Huiling Hu, Jing Dai, Shuoping Zhang, Yifan Gu, Can Dai, Jing Guo, Xinxin Xu, Yuan Li, Shunji Zhang, Liang Hu, Fei Gong, Guangxiu Lu, Ge Lin. Expanding the genetic and phenotypic spectrum of the subcortical maternal complex genes in recurrent preimplantation embryonic arrest. Clin Genet 2021 Feb;99(2):286-291.
8. Xiaojuan Wang, Yuan Li, Hongzhuan Tan, Sufen Cai, Shujuan Ma, Yangqin Peng, Hui Guo, Xiaofeng Li, Yi Tang, Shunji Zhang, Ge Lin, Fei Gong. Letrozole-stimulated endometrial preparation protocol is a superior alternative to hormone replacement treatment for frozen embryo transfer in women with polycystic ovary syndrome, a cohort study. Reprod Biol Endocrinol 2023 Oct 27;21(1):101.
9. Chen Wang, Yangqin Peng, Hui Chen, Qinmei Wang, Yu Dong, Huimin Liu, Yaoshan Yao, Shunji Zhang, Yuan Li, Sufen Cai, Xihong Li, Ge Lin, Fei Gong. Early GnRH-agonist therapy does not negatively impact the endometrial repair process or live birth rate. Front Endocrinol (Lausanne) 2024 Apr 29;15:1343176.
10. Zhang Shunji, Lin Ge, Lu Guangxiu. Analysis of pregnancy outcomes of vitrified-thawed cleavage-stage and blastocyst embryos [J]. Chinese Journal of Modern Medicine, 2011, 2108: 955-958.
11. Zhang Shunji, Lu Changfu, Tang Xiaocheng, Zhang Shuoping, Lu Guangxiu, Lin Ge. Comparison of clinical effects between closed-system vitrification and programmed freezing [J]. Journal of Reproductive Medicine, 2013, 2207: 486-490.
12. Zhang Hong, Zhang Shunji, Lu Guangxiu. Discussion on the safety of in-vitro fertilization treatment for infertile patients carrying hepatitis B virus. Chinese Journal of Physicians, 2009.06.009: 1008.
13. Gong Fei, Zong Yurong, Zhang Shunji, Zhu Wenbing, Cai Sufen, Lu Changfu, Lu Guangxiu, Lin Ge. FET after whole embryo freezing avoids the risk of moderate and severe OHSS in IVF/ICSI-ET assisted reproductive treatment [J]. Chinese Journal of Modern Medicine, 2011, 2134: 4310-4312.
14. Gong Fei, Zhang Shunji, Lu Changfu, Lin Ge, Lu Guangxiu. A case of combined transabdominal and transvaginal oocyte retrieval [J]. Journal of Practical Obstetrics and Gynecology, 2012, 2812: 1072-1073.
15. Gong Fei, Cai Sufen, Lin Ge, Zhang Shunji, Li Juan, Lu Guangxiu. A new strategy for IVF-ET treatment to prevent ovarian hyperstimulation syndrome in patients with polycystic ovary syndrome [J]. Journal of Reproductive Medicine, 2012, 2102: 102-106.
16. Cai Sufen, Zhang Shunji, Gong Fei. Discussion on the optimal trigger time of human chorionic gonadotropin in controlled ovarian hyperstimulation. Reproduction and Contraception, 2012.09: 009.
17. Song Juan, Gong Fei, Luo Keli, Zhang Shunji. Comparison of the application of long-acting and short-acting GnRH agonists in long protocol. Chinese Journal of Reproduction and Contraception, 2015.06: 0253.
18. Cai Sufen, Zhang Shunji, Li Xiaofeng, Zong Yurong, Gong Fei. Research on the application of high-purity human menopausal gonadotropin in ovulation induction treatment. Journal of Reproductive Medicine, 2016.12: 1004.